In Frimline v. K-SMATCO, Delhi HC granted interim relief over patent IN 382949, citing strong prima facie infringement of Frimline’s pharmaceutical formulation.
Read more about Frimline v. K-SMATCO: Delhi HC Rules Firmly in Pharmaceutical Patent Infringement CaseTag: patent infringement
No Territorial Jurisdiction, No Quia Timet Relief: Lessons from a Patent Case
In the case of Helsinn Healthcare SA vs AET Laboratories, the Delhi High Court declined to entertain a patent infringement action filed in anticipation of future infringement. The Court examined the territorial reach of Indian courts in web-based patent matters and reaffirmed the principles required to sustain quia timet actions.
Read more about No Territorial Jurisdiction, No Quia Timet Relief: Lessons from a Patent CaseProducts Made During Patent Term are Infringing Even After Expiry
In the case of Boehringer Ingelheim v. Femilab Healthcare, the Himachal Pradesh High Court ruled that interim injunctions granted to prevent patent infringement cannot continue after the patent has expired. The court held that such relief loses effect with the end of the patent term. However, it stated that infringing products made during the patent’s validity may still be restrained from being sold or used after the patent expires.
Read more about Products Made During Patent Term are Infringing Even After ExpiryDelhi High Court Patent Injunction: Aquestia Wins Against Automat Industries
Delhi High Court grants patent injunction to Aquestia, stopping Automat from selling Hydromat valves over suspected patent infringement.
Read more about Delhi High Court Patent Injunction: Aquestia Wins Against Automat IndustriesPatented But Still Infringing: Delhi HC Stops Hydromat Valve Sales
In the case of Aquestia Limited vs Automat Industries Private Limited & Ors., the Delhi High Court granted an interim injunction restraining the defendants from manufacturing and selling their ‘Hydromat’ valves. The court held that even a patented product can infringe an earlier patent, and found that the defendants’ valves incorporated the core features of the plaintiff’s fluid control valve patent claims.
Read more about Patented But Still Infringing: Delhi HC Stops Hydromat Valve SalesCourt Awards ₹50 Lakh to GSP Crop Science in Patent Infringement Case Over Agrochemical Formula
Delhi HC orders ₹50 lakh in damages to GSP Crop Science for patent infringement in agrochemicals, affirming seller liability under Indian patent law.
Read more about Court Awards ₹50 Lakh to GSP Crop Science in Patent Infringement Case Over Agrochemical FormulaDolby v. Lava: INR 20 Crore Deposit Ordered in SEP patent infringement case
Delhi HC directs Lava to deposit ₹20 crore as pro tem security in Dolby’s SEP infringement suit involving AAC audio tech patents.
Read more about Dolby v. Lava: INR 20 Crore Deposit Ordered in SEP patent infringement caseWho Bears the Patent Credibility Challenge Burden?
Mold Tek filed a case for infringement of its patents relating to tamper-proof plastic lids, and secured an interim injunction. The Commercial Court vacated the injunction, placing the burden of establishing validity on the patentee. The Delhi High Court reversed this, clarifying that it is the defendant’s burden to raise a credible invalidity defence under Section 107.
Read more about Who Bears the Patent Credibility Challenge Burden?Patent Upheld, Design Dismissed: Dura-Line vs. Jain Irrigation – Part 1: Infringement & Relief
This post analyzes the Delhi High Court’s decision in Dura-Line vs. Jain Irrigation, where the Court found patent infringement but rejected the design infringement claim.
Read more about Patent Upheld, Design Dismissed: Dura-Line vs. Jain Irrigation – Part 1: Infringement & ReliefWhen Dye Becomes Decisive: Patent Infringement, Equivalence, and Estoppel
In a patent infringement case, the Delhi High Court denied Crystal Crop Protection’s request for an interim injunction against Safex Chemicals. The dispute in the case centred on a herbicidal formulation containing Clodinafop, Metribuzin, and a dyeing agent. The Court held that the dye was an essential claim element and that Safex’s dye-free products did not infringe, even by equivalence. It also invoked prosecution history estoppel, noting that Crystal’s own claim amendments precluded a broad claim interpretation.
Read more about When Dye Becomes Decisive: Patent Infringement, Equivalence, and Estoppel